nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—RAMP1—migraine	0.0507	0.101	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—CALCRL—migraine	0.0507	0.101	CbGpPWpGaD
Fluocinonide—SMO—trigeminal ganglion—migraine	0.029	0.158	CbGeAlD
Fluocinonide—SMO—GPCRs, Other—EDNRA—migraine	0.0195	0.0388	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—CALCA—migraine	0.0194	0.0387	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—HTR7—migraine	0.0175	0.035	CbGpPWpGaD
Fluocinonide—Hypertrichosis—Topiramate—migraine	0.0159	0.0542	CcSEcCtD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—migraine	0.0155	0.0309	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—MEF2D—migraine	0.0151	0.0301	CbGpPWpGaD
Fluocinonide—NR3C1—nerve—migraine	0.0144	0.0786	CbGeAlD
Fluocinonide—SMO—head—migraine	0.0142	0.0773	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—RAMP1—migraine	0.0139	0.0276	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CALCRL—migraine	0.0139	0.0276	CbGpPWpGaD
Fluocinonide—SMO—nervous system—migraine	0.0134	0.0732	CbGeAlD
Fluocinonide—SMO—central nervous system—migraine	0.0129	0.0705	CbGeAlD
Fluocinonide—SMO—cerebellum—migraine	0.0126	0.0689	CbGeAlD
Fluocinonide—SMO—GPCRs, Other—HTR2A—migraine	0.0123	0.0245	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—PGR—migraine	0.0104	0.0207	CbGpPWpGaD
Fluocinonide—SMO—brain—migraine	0.0103	0.056	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—HTR1D—migraine	0.0101	0.0201	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR2B—migraine	0.00937	0.0187	CbGpPWpGaD
Fluocinonide—Glycosuria—Gabapentin—migraine	0.00887	0.0302	CcSEcCtD
Fluocinonide—Fluticasone Propionate—PGR—migraine	0.00872	0.408	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—ATP1A3—migraine	0.00842	0.0168	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PGR—migraine	0.0082	0.0163	CbGpPWpGaD
Fluocinonide—NR3C1—neck—migraine	0.0081	0.0441	CbGeAlD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.00804	0.016	CbGpPWpGaD
Fluocinonide—Betamethasone—PGR—migraine	0.00799	0.374	CrCbGaD
Fluocinonide—SERPINA6—head—migraine	0.00781	0.0425	CbGeAlD
Fluocinonide—NR3C1—Adipogenesis—MEF2D—migraine	0.00758	0.0151	CbGpPWpGaD
Fluocinonide—SERPINA6—nervous system—migraine	0.0074	0.0403	CbGeAlD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR3A—migraine	0.00716	0.0143	CbGpPWpGaD
Fluocinonide—Swelling—Valproic Acid—migraine	0.00713	0.0243	CcSEcCtD
Fluocinonide—SERPINA6—central nervous system—migraine	0.00713	0.0388	CbGeAlD
Fluocinonide—SMO—Signaling by GPCR—RAMP1—migraine	0.00712	0.0142	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CALCRL—migraine	0.00712	0.0142	CbGpPWpGaD
Fluocinonide—NR3C1—trigeminal ganglion—migraine	0.00699	0.0381	CbGeAlD
Fluocinonide—SERPINA6—cerebellum—migraine	0.00697	0.038	CbGeAlD
Fluocinonide—Skin exfoliation—Gabapentin—migraine	0.00686	0.0234	CcSEcCtD
Fluocinonide—NR3C1—brainstem—migraine	0.00619	0.0337	CbGeAlD
Fluocinonide—Nasal congestion—Timolol—migraine	0.00615	0.021	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—HTR1B—migraine	0.00611	0.0122	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.00603	0.012	CbGpPWpGaD
Fluocinonide—Swelling—Gabapentin—migraine	0.00591	0.0202	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—HTR1A—migraine	0.00588	0.0117	CbGpPWpGaD
Fluocinonide—Erythema—Propranolol—migraine	0.00581	0.0198	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—NPS—migraine	0.00579	0.0115	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—TAC1—migraine	0.00579	0.0115	CbGpPWpGaD
Fluocinonide—Dry skin—Valproic Acid—migraine	0.00577	0.0197	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—HTR2C—migraine	0.00568	0.0113	CbGpPWpGaD
Fluocinonide—SERPINA6—brain—migraine	0.00566	0.0308	CbGeAlD
Fluocinonide—NR3C1—Nuclear Receptors—ESR1—migraine	0.00554	0.011	CbGpPWpGaD
Fluocinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—migraine	0.00554	0.011	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—EDNRA—migraine	0.00552	0.011	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CALCA—migraine	0.00532	0.0106	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR1D—migraine	0.00517	0.0103	CbGpPWpGaD
Fluocinonide—NR3C1—cardiovascular system—migraine	0.00505	0.0275	CbGeAlD
Fluocinonide—Nasopharyngitis—Timolol—migraine	0.00501	0.0171	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—HTR7—migraine	0.00497	0.00991	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.00491	0.0167	CcSEcCtD
Fluocinonide—Nasal congestion—Topiramate—migraine	0.00482	0.0164	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—HTR2B—migraine	0.00481	0.00958	CbGpPWpGaD
Fluocinonide—Dry skin—Gabapentin—migraine	0.00478	0.0163	CcSEcCtD
Fluocinonide—Infection—Propranolol—migraine	0.00471	0.0161	CcSEcCtD
Fluocinonide—Nasopharyngitis—Gabapentin—migraine	0.00466	0.0159	CcSEcCtD
Fluocinonide—Dexamethasone—PGR—migraine	0.00465	0.218	CrCbGaD
Fluocinonide—Nervous system disorder—Propranolol—migraine	0.00465	0.0159	CcSEcCtD
Fluocinonide—Skin disorder—Propranolol—migraine	0.0046	0.0157	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—migraine	0.00438	0.00873	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Timolol—migraine	0.00437	0.0149	CcSEcCtD
Fluocinonide—Infection—Verapamil—migraine	0.00433	0.0148	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—CALCRL—migraine	0.00421	0.00838	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RAMP1—migraine	0.00421	0.00838	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—migraine	0.00416	0.00828	CbGpPWpGaD
Fluocinonide—Pruritus—Amitriptyline—migraine	0.00412	0.014	CcSEcCtD
Fluocinonide—Hyperglycaemia—Gabapentin—migraine	0.00407	0.0139	CcSEcCtD
Fluocinonide—Pain—Propranolol—migraine	0.00405	0.0138	CcSEcCtD
Fluocinonide—Immune system disorder—Valproic Acid—migraine	0.00393	0.0134	CcSEcCtD
Fluocinonide—Nasopharyngitis—Topiramate—migraine	0.00392	0.0134	CcSEcCtD
Fluocinonide—Dizziness—Amitriptyline—migraine	0.00385	0.0131	CcSEcCtD
Fluocinonide—Pain—Verapamil—migraine	0.00373	0.0127	CcSEcCtD
Fluocinonide—Rash—Amitriptyline—migraine	0.00367	0.0125	CcSEcCtD
Fluocinonide—Dermatitis—Amitriptyline—migraine	0.00367	0.0125	CcSEcCtD
Fluocinonide—Headache—Amitriptyline—migraine	0.00365	0.0124	CcSEcCtD
Fluocinonide—Immune system disorder—Timolol—migraine	0.0035	0.0119	CcSEcCtD
Fluocinonide—Hypersensitivity—Propranolol—migraine	0.00349	0.0119	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—HTR2A—migraine	0.00348	0.00694	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Topiramate—migraine	0.00342	0.0117	CcSEcCtD
Fluocinonide—NR3C1—head—migraine	0.00342	0.0186	CbGeAlD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—migraine	0.00341	0.00678	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—ESR1—migraine	0.0034	0.00677	CbGpPWpGaD
Fluocinonide—Erythema—Timolol—migraine	0.00337	0.0115	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TAC1—migraine	0.00335	0.00668	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—migraine	0.00329	0.00655	CbGpPWpGaD
Fluocinonide—Immune system disorder—Gabapentin—migraine	0.00326	0.0111	CcSEcCtD
Fluocinonide—NR3C1—nervous system—migraine	0.00324	0.0177	CbGeAlD
Fluocinonide—Hypersensitivity—Verapamil—migraine	0.00321	0.011	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.0032	0.0109	CcSEcCtD
Fluocinonide—Erythema—Gabapentin—migraine	0.00314	0.0107	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—HTR1B—migraine	0.00313	0.00625	CbGpPWpGaD
Fluocinonide—Dizziness—Propranolol—migraine	0.00313	0.0107	CcSEcCtD
Fluocinonide—NR3C1—central nervous system—migraine	0.00312	0.017	CbGeAlD
Fluocinonide—Pruritus—Verapamil—migraine	0.00308	0.0105	CcSEcCtD
Fluocinonide—Infection—Valproic Acid—migraine	0.00307	0.0105	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—FOS—migraine	0.00306	0.0061	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR1D—migraine	0.00306	0.00609	CbGpPWpGaD
Fluocinonide—NR3C1—cerebellum—migraine	0.00305	0.0166	CbGeAlD
Fluocinonide—Nervous system disorder—Valproic Acid—migraine	0.00303	0.0103	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	0.00303	0.00603	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR1A—migraine	0.00302	0.00601	CbGpPWpGaD
Fluocinonide—Skin disorder—Valproic Acid—migraine	0.003	0.0102	CcSEcCtD
Fluocinonide—Rash—Propranolol—migraine	0.00299	0.0102	CcSEcCtD
Fluocinonide—Dermatitis—Propranolol—migraine	0.00299	0.0102	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—NPS—migraine	0.00297	0.00592	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—TAC1—migraine	0.00297	0.00592	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.00292	0.00582	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR2C—migraine	0.00291	0.00581	CbGpPWpGaD
Fluocinonide—Dizziness—Verapamil—migraine	0.00288	0.00983	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00285	0.00972	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—HTR2B—migraine	0.00284	0.00566	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EDNRA—migraine	0.00284	0.00565	CbGpPWpGaD
Fluocinonide—Rash—Verapamil—migraine	0.00275	0.00938	CcSEcCtD
Fluocinonide—Dermatitis—Verapamil—migraine	0.00275	0.00937	CcSEcCtD
Fluocinonide—Immune system disorder—Topiramate—migraine	0.00274	0.00935	CcSEcCtD
Fluocinonide—Infection—Timolol—migraine	0.00273	0.00933	CcSEcCtD
Fluocinonide—Headache—Verapamil—migraine	0.00273	0.00932	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CALCA—migraine	0.00273	0.00544	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	0.00273	0.00543	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—migraine	0.0027	0.00538	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Timolol—migraine	0.0027	0.00921	CcSEcCtD
Fluocinonide—Skin disorder—Timolol—migraine	0.00267	0.00912	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00265	0.00906	CcSEcCtD
Fluocinonide—Pain—Valproic Acid—migraine	0.00264	0.00902	CcSEcCtD
Fluocinonide—Erythema—Topiramate—migraine	0.00264	0.00901	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—HTR7—migraine	0.00255	0.00509	CbGpPWpGaD
Fluocinonide—Infection—Gabapentin—migraine	0.00255	0.00868	CcSEcCtD
Fluocinonide—Nervous system disorder—Gabapentin—migraine	0.00251	0.00857	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—LRP1—migraine	0.0025	0.00498	CbGpPWpGaD
Fluocinonide—Skin disorder—Gabapentin—migraine	0.00249	0.00849	CcSEcCtD
Fluocinonide—NR3C1—brain—migraine	0.00248	0.0135	CbGeAlD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—migraine	0.00239	0.00476	CbGpPWpGaD
Fluocinonide—Pain—Timolol—migraine	0.00235	0.00803	CcSEcCtD
Fluocinonide—Hypersensitivity—Valproic Acid—migraine	0.00228	0.00777	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.00223	0.00762	CcSEcCtD
Fluocinonide—Pain—Gabapentin—migraine	0.00219	0.00748	CcSEcCtD
Fluocinonide—Pruritus—Valproic Acid—migraine	0.00219	0.00746	CcSEcCtD
Fluocinonide—Infection—Topiramate—migraine	0.00214	0.00731	CcSEcCtD
Fluocinonide—Nervous system disorder—Topiramate—migraine	0.00211	0.00721	CcSEcCtD
Fluocinonide—Skin disorder—Topiramate—migraine	0.00209	0.00714	CcSEcCtD
Fluocinonide—Dizziness—Valproic Acid—migraine	0.00204	0.00697	CcSEcCtD
Fluocinonide—Hypersensitivity—Timolol—migraine	0.00203	0.00692	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—migraine	0.00202	0.00402	CbGpPWpGaD
Fluocinonide—Rash—Valproic Acid—migraine	0.00195	0.00665	CcSEcCtD
Fluocinonide—Dermatitis—Valproic Acid—migraine	0.00195	0.00664	CcSEcCtD
Fluocinonide—Pruritus—Timolol—migraine	0.00195	0.00664	CcSEcCtD
Fluocinonide—Headache—Valproic Acid—migraine	0.00194	0.00661	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—NOTCH4—migraine	0.00192	0.00382	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Gabapentin—migraine	0.00189	0.00644	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—HTR1B—migraine	0.00185	0.00369	CbGpPWpGaD
Fluocinonide—Pain—Topiramate—migraine	0.00184	0.00629	CcSEcCtD
Fluocinonide—Dizziness—Timolol—migraine	0.00182	0.00621	CcSEcCtD
Fluocinonide—Pruritus—Gabapentin—migraine	0.00181	0.00618	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—HTR2A—migraine	0.00179	0.00356	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR1A—migraine	0.00178	0.00355	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TAC1—migraine	0.00176	0.0035	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NPS—migraine	0.00176	0.0035	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PGR—migraine	0.00176	0.0035	CbGpPWpGaD
Fluocinonide—Rash—Timolol—migraine	0.00174	0.00592	CcSEcCtD
Fluocinonide—Dermatitis—Timolol—migraine	0.00173	0.00591	CcSEcCtD
Fluocinonide—Headache—Timolol—migraine	0.00172	0.00588	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—HTR2C—migraine	0.00172	0.00343	CbGpPWpGaD
Fluocinonide—Dizziness—Gabapentin—migraine	0.00169	0.00578	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—EDNRA—migraine	0.00167	0.00334	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH3—migraine	0.00163	0.00325	CbGpPWpGaD
Fluocinonide—Rash—Gabapentin—migraine	0.00162	0.00551	CcSEcCtD
Fluocinonide—Dermatitis—Gabapentin—migraine	0.00161	0.00551	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—CALCA—migraine	0.00161	0.00321	CbGpPWpGaD
Fluocinonide—Headache—Gabapentin—migraine	0.00161	0.00548	CcSEcCtD
Fluocinonide—Hypersensitivity—Topiramate—migraine	0.00159	0.00542	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH4—migraine	0.00155	0.00309	CbGpPWpGaD
Fluocinonide—Pruritus—Topiramate—migraine	0.00153	0.0052	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—HTR7—migraine	0.00151	0.003	CbGpPWpGaD
Fluocinonide—Dizziness—Topiramate—migraine	0.00143	0.00486	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—PGR—migraine	0.00142	0.00282	CbGpPWpGaD
Fluocinonide—Rash—Topiramate—migraine	0.00136	0.00464	CcSEcCtD
Fluocinonide—Dermatitis—Topiramate—migraine	0.00136	0.00463	CcSEcCtD
Fluocinonide—Headache—Topiramate—migraine	0.00135	0.00461	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH3—migraine	0.00132	0.00262	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFBR2—migraine	0.0013	0.00259	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR2A—migraine	0.00106	0.0021	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—migraine	0.001	0.002	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ESR1—migraine	0.000937	0.00187	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—migraine	0.000868	0.00173	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR1—migraine	0.000757	0.00151	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH4—migraine	0.000746	0.00149	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PGR—migraine	0.000682	0.00136	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH3—migraine	0.000634	0.00126	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR1—migraine	0.000364	0.000726	CbGpPWpGaD
